# US 2012/0251437 A1 · Magnetite in nanoparticulate form

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251437 A1
- Document ID: US20120251437A1
- Status: Published application
- Kind: A1
- Application number: 13/516,166
- Filed: 2010-12-15
- Published: 2012-10-04
- Earliest claimed: 2009-12-15
- Assignees: Colorobbia Italia S.P.A.
- Inventors: Marco Bitossi; Giovanni Baldi; Franco Innocenti
- Web page: https://patentgrep.com/patent/US20120251437A1

## CPC

- A61K 49/1806: {Suspensions, emulsions, colloids, dispersions}
- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- A61K 33/26: Iron; Compounds thereof
- A61K 41/0052: {Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy}
- A61N 2/004: {specially adapted for a specific therapy}
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- C01G 49/08: Ferroso-ferric oxide [Fe3O4]
- C01P 2004/64: Nanometer sized, i.e. from 1-100 nanometer
- C01P 2006/42: Magnetic properties
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- C01G: COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F (metal hydrides {monoborane, diborane or addition complexes thereof} C01B6/00; salts of oxyacids of halogens C01B11/00; peroxides, salts or peroxyacids C01B15/00; thiosulfates, dithionites, polythionates C01B17/64; compounds containing selenium, or tellurium C01B19/00; binary compounds of nitrogen with metals C01B21/06; azides C01B21/08; {compounds containing nitrogen, other non-metals and metal C01B21/082}; metal amides C01B21/092; nitrites C01B21/50; {compounds of noble gases C01B23/0005}; phosphides C01B25/08; salts of oxyacids of phosphorus C01B25/16; carbides C01B32/90; compounds containing silicon C01B33/00; compounds containing boron C01B35/00; compounds having molecular sieve properties but not having base-exchange properties C01B37/00; compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites, C01B39/00; cyanides C01C3/08; salts of cyanamide C01C3/16; thiocyanates C01C3/20)
- C01P: INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS

## Abstract

The present invention relates to a process for the polyol-type synthesis of nanoparticulate magnetite starting from mixtures of Fe0 and FelIII in the presence of a mineral acid. The magnetite particles obtainable from the process have uniform size characteristics and have even presented higher SAR (Specific Absorption Rate) values than those of magnetosomes.

## Claims

### Claim 1

Polyol-type process for preparing magnetite nanoparticles, said process comprising a step (ii) wherein said nanoparticles are prepared in a polyalcohol solvent starting from metallic iron and FeIII in the presence of a catalyst and a suitable quantity of water.

### Claim 2 (depends on 1)

Process according to claim 1 wherein the water is present in a molar amount equal to 1.5-5 times the moles of the FeIII salt used.

### Claim 3 (depends on 1, 2)

Process according to any one of claims 1-2 wherein said polyalcohol solvent is chosen from the group glycerine, propylene glycol and ethylene glycol.

### Claim 4 (depends on 1, 2, 3)

Process according to any one of claims 1-3 wherein said catalyst is chosen from mineral acids.

### Claim 5 (depends on 1, 2, 3, 4)

Process according to any one of claims 1-4 wherein the precursors of said FeIII are salts soluble in a polyalcohol solvent.

### Claim 6 (depends on 1, 2, 3, 4, 5)

Process according to any one of claims 1-5 wherein said FeIII is added to the reaction mixture in the form of a polyalcohol solution.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

Process according to any one of claims 1-6 wherein said FeIII is added to the reaction mixture in consecutive portions or at a controlled rate such that the reaction mixture does not undergo considerable temperature variations during the addition.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

Process according to any one of claims 1-7 wherein said process is preceded by a preparation step (i) of a polyalcohol solution of FeIII starting from Fe0, wherein said step (i) comprises the following steps:
(a) preparing a FeII solution starting from Fe0 in a polyalcohol solvent and in the presence of an organic acid;
(b) preparing a FeIII solution by bubbling air into the solution obtained from step (a);
and wherein the FeIII solution obtained from step (b) is used in step (ii).

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

Nanoparticulate magnetite obtainable by the process according to any one of claims 1-8.

### Claim 10 (depends on 9)

Use of the magnetite according to claim 9 for preparing theranostic compositions for the hyperthermic and/or diagnostic treatment (by means of MRI) of tumours
